Jonathan Young

Co-Founder, EVP and COO, Akero Therapeutics.

[akerotx @akerotx]

$AKRO to present preliminary topline week 96 results from the Phase 2b SYMMETRY study investigating #EFX in patients with compensated cirrhosis (F4) due to #MASH on Monday at 8:00 AM ET: https://t.co/utMqbqXRHg.

Register for the presentation here:
https://t.co/RDVDktHpCQ.

[akerotx @akerotx]

Today, $AKRO announces pricing of underwritten offering of common stock. Read more: https://t.co/SwMlsmnkm5

[Jonathan Young @JonathanYoungTx]

via @NYTimes https://t.co/WFK3x9LfdO

[Jonathan Young @JonathanYoungTx]

Statement from President Joe Biden on the Passing of Judith Heumann | The White House https://t.co/wpFMrwFUFZ

[New York Times Opinion @nytopinion]

The disability rights activist Judith Heumann has died. https://t.co/IgRl0VCSRt

"One of the most profound outcomes of the passage of the A.D.A. has been the gain of dignity and self-worth for disabled persons," she and @wodatch_john wrote in 2020. https://t.co/aQ3GBCGqYB

[Bill Clinton @BillClinton]

Judy Heumann spent a lifetime breaking down barriers and helping others reach their full potential. I’ll always be grateful for her outstanding work in my Administration creating opportunities for all of America’s children. Hillary and I will miss her very much. https://t.co/u313vQTZF2

[EIN SOF Comm @EINSOFComm]

Thanks Joe Shapiro for a empowering tribute to Judy Heumann on NPR. Speak her name, know her efforts with the first generation of disability rights leaders in American Coalition of Citizens with Disabilities and others who revolu…https://t.co/YTXG8nhf0j https://t.co/cxpfsJv7Xn

[Judy Heumann Legacy @judithheumann]

Thank you to everyone who has followed and supported Judy throughout her lifetime of advocacy. May her memory be for a blessing.

https://t.co/BzQSXux9bj

[Jonathan Young @JonathanYoungTx]

I join fellow advocates around the world mourning the passing of @judithheumann Few people have done as much for people with disabilities—and for as long with such a global reach. Thank you Judy. An honor to be just one of countless lives you’ve transformed

[Tony Coelho @HonTonyCoelho]

I’m deeply saddened by the passing of Judy Heumann; a dear friend & confidant for decades.

She was our rock. Our Godmother. Our cheerleader. And our conscience. The fight for disability rights is where it is because of her involvement. We love you Judy. Rest In Peace.

[akerotx @akerotx]

$AKRO reports positive, statistically significant topline results for both #EFX doses on key histology endpoints in the Ph2b HARMONY study of EFX in F2/F3 #NASH #fibrosis: https://t.co/vmpjYu5oq8 Tune in to the data presentation at 8AM ET to learn more: https://t.co/eXVhocb0SW

[Carolina Basketball @UNC_Basketball]

We're going to the NATIONAL CHAMPIONSHIP!!

[Jonathan Young @JonathanYoungTx]

GO HEELS!!!!!!

[Jonathan Young @JonathanYoungTx]

Tight game with #UNC shooting just 35% — big half coming up for #Tarheels. Go heels!!!

[Jonathan Young @JonathanYoungTx]

Happy birthday #ADA31! Great to see President Biden blaze new ground with today’s announcement about long Covid.

[CSPAN @cspan]

President Biden: "I'm proud to announce a new effort, the first of its kind, to help Americans grappling with long term effects of COVID-19 that doctors call 'Long COVID'."

Full #ADA31 video here: https://t.co/lZ0J5lDYIn

[CSPAN @cspan]

President Biden: "I'm proud to announce a new effort, the first of its kind, to help Americans grappling with long term effects of COVID-19 that doctors call 'Long COVID'."

Full #ADA31 video here: https://t.co/lZ0J5lDYIn

[akerotx @akerotx]

We're excited to share additional analyses from our Phase 2a BALANCED study in #patients with #NASH and F1-F3 #fibrosis in two poster presentations at #ILC2021!
@EASLnews
PO-1314: https://t.co/TdPAXQoSN2
PO-1762: https://t.co/VbDJDAZWZW

[akerotx @akerotx]

Today is the start of @ADA_DiabetesPro 81st Scientific Sessions, and we're presenting two posters on metabolic and #liver effects of #EFX in patients with #NASH and those with #diabetes. Learn about our efforts in the #ADA2021 showcase video!
#LiverTwitter
https://t.co/ZKZKKMZygD

[akerotx @akerotx]

Akero is proud to amplify the voices of individual patients, doctors, caregivers, and our own team members, spreading the word about #NASH and #fattyliver disease today on #NASHday, and every day! #NAFLD #LiverTwitter @Pinnacle_TX @ClinicalTandem @research_texas

[akerotx @akerotx]

We look forward to five presentations at the @EASLnews and @ADA_DiabetesPro scientific conferences in June, including a late-breaker oral presentation of Cohort C results from the Phase 2a BALANCED study in F4 #NASH patients!
#ADA2021 #ILC2021 #fibrosis
https://t.co/r9Zv2dWhT9

[Jonathan Young @JonathanYoungTx]

What an awesome achievement tonight! Incredible segment of Judy Heumann at the Oscars! #CripCamp